News
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 22, 2021Courtney Bartlett DNP, ACNP-BC, RNFA to Lead Clinical Translation of Company's Regenerative Immunotherapy Pipeline
(OTC-CELZ) Creative Medical Technology Holdings announced today recruitment of Dr. Courtney Bartlett to lead clinical development of the Company's pipeline of therapeutic products. Dr. Bartlett...
-
Jun 17, 2021
Creative Medical Technology Holdings, Inc. (OTC - CELZ), announced that the company will virtually present at the Investor Forum at the World Stem Cell Summit today Thursday, June 17, 2021 at...
-
Jun 9, 2021Clinical Stage Regenerative Immunotherapy Company Optimizes Treatment for Diabetes as it Prepares for Additional Investigational New Drug Application
Creative Medical Technology Holdings, trading under Ticker Symbol CELZ, announced the filing of a provisional patent application in connection with new data indicating that the Company's ImmCelz®...
-
May 24, 2021Clinical Stage Biotechnology Company Reports Patent Filing based on Preclinical Data using "Regenerative Immunotherapy" Approach
Creative Medical Technology Holdings, trading under ticker symbol CELZ, announced today positive preclinical data supporting extension of ImmCelz® applicability to Parkinson's Disease. Using the...
-
May 20, 2021Immunologist Surgeon who Invented Islet Transplantation to Assist Company in Advancing ImmCelz® Platform
Creative Medical Technology Holdings announced today recruitment of Dr. Camillo Ricordi to the Company's Scientific Advisory Board. Dr. Ricordi will collaborate with Company Advisors such as Drs...